Markets Insider: Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, announced that it is now offering access to Eli Lilly and Company’s newly FDA-approved ... Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect The Holy Mess on MSN: New Weight Watchers Plan 2025 Plan Started November 2022 Weight Watchers has established an interim office of the CEO, with Chief Financial Officer Felicia DellaFortuna and Chief Operations Officer Jon Volkmann serving as principal offi ...

Understanding the Context

Seeking Alpha: Weight Watchers reinvents itself to capitalize on GLP-1 boom with new platform WW International (WW), more commonly known as Weight Watchers, is fully embracing the popularity of GLP-1s and their impact on weight loss management with a new platform that integrates GLP-1 ... Weight Watchers reinvents itself to capitalize on GLP-1 boom with new platform